Susquehanna Portfolio Strategies’s Relay Therapeutics RLAY Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.37M	Hold	339,080	–	–	0.05%	379
2025 Q4	$2.87M	Hold	339,080	–	–	0.04%	426
2025 Q3	$1.77M	Buy	339,080 +100,266	+42%	+$382K	0.03%	536
2025 Q2	$826K	Buy	+238,814	New	+$710K	0.02%	549
2024 Q4	–	Sell	-130,000	Closed	-$920K	–	263
2024 Q3	$920K	Sell	130,000 -78,356	-38%	-$585K	0.06%	203
2024 Q2	$1.36M	Hold	208,356	–	–	0.06%	254
2024 Q1	$1.73M	Sell	208,356 -1,647	-0.8%	-$16.1K	0.04%	360
2023 Q4	$2.31M	Buy	+210,003	New	+$1.77M	0.04%	402

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return